Investigational Drug Details
| Drug ID: | D031 |
| Drug Name: | Besifovir |
| Synonyms: | Besifovir |
| Type: | Chemical drug |
| DrugBank ID: | DB15671 |
| DrugBank Description: | -- |
| PubChem ID: | 5270766 |
| CasNo: | 441785-25-7 |
| Repositioning for NAFLD: | No |
| SMILES: | C(C1(OCP(=O)(O)O)CC1)n1c2c(nc1)cnc(n2)N |
| Structure: |
|
| InChiKey: | KDNSSKPZBDNJDF-UHFFFAOYSA-N |
| Molecular Weight: | 299.227 |
| DrugBank Targets: | -- |
| DrugBank MoA: | -- |
| DrugBank Pharmacology: | -- |
| DrugBank Indication: | -- |
| Targets: | DNA-directed DNA polymerase; Hepatitis B virus replication |
| Therapeutic Category: | -- |
| Clinical Trial Progress: | Phase 4 on-going (NCT03604016) |
| Latest Progress: | Under clinical trials |
| Trial ID | Source ID | Phases | Status | Study Results | Start Date | Last Update Posted | |
|---|---|---|---|---|---|---|---|
| L0790 | NCT03604016 | Phase 4 | Not recruiting | No Results Available | 19/07/2018 | 12 December 2020 | Details |
| Target ID | Target Name | GENE | Action | Class | UniProtKB ID | Entry Name |
|---|
| Strategy ID | Strategy | Synonyms | Related Targets | Related Drugs |
|---|
| Article ID | PMID | Source | Title |
|---|